The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus Adenocarcinoma

NCT00674167 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Docetaxel
DRUG: Cisplatin
DRUG: Capecitabine

Sponsor

National University Hospital, Singapore